So, you’re looking to get a handle on quantum mechanics, huh? It’s a bit of a beast, not gonna lie. But the good news is, ...

Schrödinger announced it will release its third quarter 2025 financial results on November 5, 2025, followed by a live webcast and conference call for investors. The company has attracted increasing ...

The logistic map looks simple but it reveals how chaos emerges from order. This story shows why one equation changes how we see the world. Who Trump Officials Deem Essential in Shutdown Raises ...

NEW YORK--(BUSINESS WIRE)--Schrödinger, Inc. (Nasdaq: SDGR) today announced the discontinuation of the clinical development program for SGR-2921, its CDC7 inhibitor, which was being evaluated in a ...

Schrödinger has halted development of its cancer-fighting candidate SGR-2921 after two patients treated with the cell division cycle 7 (CDC7) inhibitor died in a Phase I trial. The trial (NCT05961839) ...

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. Founded in 1993 in Alexandria, VA., by brothers David and Tom ...

A group of scientists led by Portuguese research center Instituto de Telecomunicações and the University of Lisbon has utilized the so-called Arrhenius equation to assess the reliability of ...

Schrodinger has won U.S. Food and Drug Administration fast-track designation for its SGR-1505 drug candidate in a rare type of non-Hodgkin's lymphoma. Schrodinger on Friday said the designation covers ...

Schrödinger is laying off 60 staffers, or about 7% of its workforce, in an effort to save cash and boost efficiency. The restructuring is designed to cut costs by $30 million annually, with half of ...